Local Institution - 0092 — Atlanta, Georgia

Public research footprint of Local Institution - 0092, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Melanoma · Lymphoma, Large B-Cell, Diffuse · Stage IV or Recurrent Non-Small Cell Lung Cancer · Relapsed or Refractory Multiple Myeloma

Recently updated registry entries

NCT03383458 — A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk… (Active Not Recruiting)
NCT07100080 — Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated… (Recruiting)
NCT05076175 — A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Local Institution - 0092?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.